| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 |
| Sale of Products | 8,369.59 | 7,546.76 | 6,665.96 | 6,333.04 |
| Sale of Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 8,217.82 | 8,198.61 | 6,508.13 | 7,210.11 |
| Property, Plant and Equipments | 3,139.40 | 2,626.67 | 2,575.08 | 2,757.79 |
| Right-of-Use Assets | 157.57 | 144.93 | 127.51 | 125.55 |
| Intangible Assets | 4,841.14 | 5,349.85 | 3,720.06 | 4,181.29 |
| Market Cap (Rs in Crs) | 1,10,153.97 | |
|---|---|---|
| P/E | 60.39 | |
| Book Value (Rs) | 222.39 | |
| Div (%) | 560 | |
| Market Lot | 1 | |
| EPS (TTM) | 53.9 | |
|---|---|---|
| Price/Book | 14.64 | |
| Div Yield.(%) | 0.86 | |
| Face value (RS) | 5 | |
| Deliverables (%) | 58.03 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 4,20,135.55 | 1,751.05 | 1,692.65 | 3.45 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,49,680.48 | 5,638.35 | 5,757.50 | -2.07 | 6,448.75 - 3,640.10 |
| Cipla Ltd | 1,22,390.34 | 1,515.45 | 1,496.50 | 1.27 | 1,702.00 - 1,310.05 |
| Mankind Pharma ... | 1,06,554.59 | 2,582.65 | 2,522.45 | 2.39 | 3,050.00 - 1,910.10 |
| Dr Reddys Labor... | 97,105.57 | 1,163.70 | 1,159.50 | 0.36 | 1,420.20 - 1,025.90 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 5,52,89,946 | 16.34 |
| Total Institutions | 2,82,53,746 | 8.35 |
| Total Govt Holding | 6,816 | 0.00 |
| Total Non Promoter Corporate Holding | 14,53,043 | 0.43 |
| Total Promoters | 23,11,85,400 | 68.31 |
| Total Public & others | 22256489 | 6.58 |
| Total | 33,84,45,440 | 100 |
